Relay Therapeutics, Inc.
- RLAY
- NASDAQ
- Biotechnology
- Precision Oncology Drugs
- Small Molecule Therapeutics
- Structure-Based Drug Discovery
$17.09
Today +4.98%Quote Oct 19, 2026, 08:00 PM UTC
−9.29%over the last month
Max drawdown −16.0%From 1-month high −11.9%3 months −11.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Relay Therapeutics
Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
202
Founded
2015
Market value
$3.75B
Quote Oct 19
Floor
$16.91
1.0% below price
Resistance
$17.03
Price is above this level
Price vs analyst targets
15 analysts
Lowest target
$18.00Highest target
$31.00
$18.00Highest target
$31.00
- Price $17.09
- Average target $26.25
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 54% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RLAYPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free